News report 📈 Stocks 📊 Neutral 🌍 United Kingdom

THG Revenue Climbs 7.2% as Adjusted EBITDA More Than Doubles in H1 2026

THG reports robust H1 2026 growth driven by a 57% surge in Myprotein unit volumes and expansion in its Beauty division, as management reiterates positive full-year free cash flow guidance.

🕐 1 min read
Impact
10/10

💡 Key Takeaways

  • Myprotein branded unit volumes jumped 57% to 58.5 million, cementing its position as a key growth driver.
  • Restructuring efforts and the demerger of THG Ingenuity have successfully shifted the group toward a capital-light operating model.
  • Management expects revenue growth to accelerate to 6%–7% in the fourth quarter of 2026.
  • The company is targeting a net debt leverage of approximately 1x by the end of 2027, with potential for a net cash-positive position.

📋 Executive Summary

THG Plc reported a strong first half for 2026, with revenue rising 7.2% to £828.7 million and adjusted EBITDA more than doubling to £42.8 million. The company successfully pivoted to a capital-light model following the Ingenuity demerger and remains on track to meet its full-year free cash flow target of £25 million to £35 million.

📊 Sentiment Analysis

Sentiment
📊 Neutral
Impact Score
10/10
Region
🌍 United Kingdom
Asset Class
📈 Stocks

❓ Frequently Asked Questions

📰 Source

📅 Originally published:
🔗 View Original Article

⚠️ Disclaimer: This content is for training purposes only and should not be considered financial advice. Always conduct your own research before making investment decisions.